Group items tagged

Or mat & mince comme coupe spec shorts, les analystes s'attendent à des pertes de la Fed après Le prix de l'or bordé de 10 $ par once plus bas lundi matin quels concessionnaires appelés « terne, mince » commerce suite saut pointu de vendredi sur les données d'emplois aux États-Unis. Une montée subite dans asiatique partage prix - attribués au gagnant de Tokyo les Jeux olympiques de 2020 offre, de plus les nouvelles officielles de croissance annuelle de 7 % dans les exportations de la Chine et les importations en août - n'a pas pas soulever les marchés boursiers européens. Or est retombé à 1 382 $ comme produits de base a également diminué avec les prix des obligations publiques européennes principales. Argent perdu 1,5 % d'arrivée de vendredi, atteinte après que les données d'emplois américains plus faibles que prévu vu le métal précieux regagner la perte de près de 4 % - de la veille. "Or grimpé plus de $30 par conséquent," stratège de Mitsubishi notes Jonathan Butler, « aux attentes des importantes QE s'amenuisant ont été repoussé au-delà de septembre. »Si or efface avec succès le niveau 1 400 $, le prochain arrêt technique est d'environ 1 435 $. » Mais "avec beaucoup d'analystes appelant pour effiler pour démarrer en septembre", estime le courtier Marex Spectron, " cela limitera la hausse [à prix d'or et d'argent]." Si ce n'était pas pour la situation syrienne, nous serions plus faibles." Pointant vers le pic de la semaine dernière de 3 % à taux de rendement 10 ans du Trésor américain, "Gold [avait] pensons certaine pression de la hausse des taux d'intérêt," déclare Edward Meir, écrivant pour les courtiers INTL FC Pierre. Grâce à contradictoires données américaines, "Confusion empêchera probablement or d'affaiblir considérablement au cours de cette semaine," a-t-il ajouté, "mais nous soupçonnons que la vente devrait s'intensifier après que la réunion de la Fed est de la route." « Le

Alvin M. Weinberg introduced the term "big science" into the national lexicon in 1961. Big science is research that requires the coordination of massive resources, including thousands of our best minds and cutting-edge technologies to solve massive, complex problems. With visionary gusto, Weinberg wrote that "the monuments of big science, the huge rockets, the high-energy accelerators, the high-flux research reactors ... will be symbols of our time as surely as Notre Dame is a symbol of the Middle Ages." The concept of big science is especially timely in a highly charged political environment with the debate focused on the Affordable Care Act, streamlining services and controlling costs. As a result, vital research often gets short shrift. Big science is expensive and time-consuming, but the results can have exponential benefits: the potential for dramatically improved health outcomes throughout the world.

Hi. I am Art Caplan, from the NYU Langone Medical Center, Division of Medical Ethics. What is going on in the field of regenerative medicine with respect to stem cell research? We have recently had yet another in a long series of scandals involving claims about the ability to manipulate stem cells in ways that turned out to be utterly untrue and fraudulent. In this case, a scientist in Japan said that she was able to make adult stem cells revert to embryo-like stem cells with some pretty simple chemical exposures. It was announced in leading journals and covered extensively by the media. Then she had to admit that no one could duplicate what she had done and confessed that she had made it up. This is not the first time that this has happened in the stem cell field. Going back all the way to right after Dolly the sheep was cloned, people were trying to clone human embryos to see if they could get cloned human embryos from stem cells. A group in Korea announced that they had made the first cloned human embryos. Nobody could replicate what they did, and they ultimately had to retract their claims published in leading scientific journals that they had cloned human embryos. Stem cell research seems again and again to go off the rails when it comes to the ethics of research. What is going on and why is that so? I think there are a couple of reasons why this particular area has gotten itself in so much hot water. One is that there is a relative shortage of funding. Because of the controversial nature of cloning -- getting stem cells from human embryos -- some avenues of funding have dried up, and it puts pressure on people to come up with other ways to try to make human stem cells. With less funding, there is more pressure. Sometimes people cut corners. I think that can l